Alexander Bertram
University Lecturer @Medizinische Hochschule Brandenburg
Signup · Get unlimited contacts
WORK HISTORY
University Lecturer @Medizinische Hochschule Brandenburg
Brandenburg/Havel, DE
Biochemistry teaching to medical and dental students (full curriculum, 1st to 5th year)• Focus areas: immunology, molecular biology, oncology, hormones, metabolism & regulation, antibiotics• Curriculum planning & course content preparation• Juror in university candidate selection process (oral entry exam)• Examiner of semester-end examinations (oral exams & poster congress)
EDUCATION
The University of Kansas
M.A., Microbiology
University of Hamburg
Pre-Diploma, Biology
FernUniversität in Hagen
PG Cert. Bus. Admin., finance/investment, tax, cost control
Universität Marburg
Dr., Microbiology
SKILLS
ABOUT ALEXANDER BERTRAM
Entrepreneurial pharma executive with 20+ years of experience at the intersection of Strategic Alliances, Negotiation and Strategy. Proven track record in leading complex international collaborations with academic institutions, key opinion leaders (KOLs), and industry partners across oncology, cardiovascular diseases, and other specialty care areas.Experienced in translating strategic intent into impactful external partnerships, enabling translational insight generation, evidence-building initiatives, and trustful long-term stakeholder engagement.Core expertise lies in designing, negotiating, and executing strategic alliances and license agreements across the pharmaceutical value chain, with a strong focus on scientific collaboration, cross-functional alignment, and sustainable partnership governance.Selected strengths include: • Strategic alliance leadership and external engagement in complex multi-stakeholder environments • KOL and academic network development across Europe, North America and Asia • Negotiation and structuring of high-value licensing and collaboration agreements • Integration of medical, R&D, and commercial perspectives into unified strategies • Venture capital, biotech leadership, and executive-level decision consulting experienceIndustry exposure spans ethical pharmaceuticals, oncology, cardiovascular diseases, women’s health, dermatology, CNS, biosimilars, OTC, and emerging modalities across global markets.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.